Drug Discovery World

JULY 5, 2023

Decades of research on the cellular and molecular mechanisms of how the immune system detects and kills cancerous or pre-cancerous cells, known as immune surveillance, and the factors which modulate that response, have led to understanding how we can enable a patient’s own immune system to fight cancer more efficiently in different ways.

Research 98

Research Protein Scientist Immune Response 98

The Pharma Data

JUNE 1, 2022

Blocking an immune response-related enzyme holds promise in preventing or treating severe COVID-19 symptoms by reducing inflammation, tissue injury and blood clots in the lungs, new research in mice suggests. Previous research has shown that caspase 11 in mice has many of the same immune-response functions as caspase 4 in humans.

Immune Response 52

Immune Response Genetic Engineering Engineer Research 52

pharmaphorum

SEPTEMBER 4, 2020

Personalized and precision medicines are exciting fields that focus on the development of treatment and prevention strategies for a single patient or patient group. Personalized and precision medicine, however, can offer specialized treatments that target the patient’s unique cancer subtype, its genetic mutations, and the affected tissues.

Medicine 59

Medicine Production Genetic Engineering Genetics 59

XTalks

AUGUST 17, 2020

Treatment vaccines : these boost the immune system responses to target cells. Immune system modulators (i.e. receptors) of the immune system to enhance, or suppress immune responses. Suri, as the company’s approach is “a very unique marriage between very rational protein engineering and immunology.”.

Protein 98

Protein Engineer Immune Response In-Vivo 98

Drug Discovery World

JULY 22, 2022

Immunotherapies have become more popular due to their ability to trigger and train the patient’s immune system to recognise and attack tumour cells, provide strong immune responses, and reduce the severity of adverse side effects generally associated with chemotherapies. After earning a B.A. References.

In-Vivo 52

In-Vivo Engineer In-Vitro Antibody 52

Drug Discovery World

FEBRUARY 3, 2023

The surviving control animal, which responded similarly to the vaccinated animals, surprised the scientists, and they plan additional studies of possible cross-protective immune responses.

Vaccination 52

Vaccination Vaccine Genetic Engineering Protein 52

The Pharma Data

SEPTEMBER 8, 2020

About AstraZeneca AstraZeneca (LSE/STO/NYSE: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology.

Vaccination 52

Vaccination Vaccine Containment Clinical Trials 52

The Pharma Data

SEPTEMBER 8, 2020

(LSE/STO/NYSE: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Cambridge, UK.

Vaccination 52

Vaccination Vaccine Containment Clinical Trials 52

Drug Discovery World

FEBRUARY 15, 2023

Cancer is a complex heterogenous multistep disease characterised by uncontrolled cell proliferation combined with a dysregulated immune response. A healthy immune system is naturally primed to eliminate malignant and abnormal cells through a synchronised and dynamic interplay between adaptive and innate immunity.

Research 52

Research In-Vitro In-Vivo Development 52

Drug Discovery World

NOVEMBER 8, 2023

Annemie Deiteren, MD, PhD, Director, Translational Medicine & Clinical Pharmacology, Translational Medicine & Early Development, Sanofi, on: ‘Multispecific, multivalent TSLP-IL13 NANOBODY’. Chairperson Mark Chiu, on: ‘Strategies to enhance efficacy of a tetraspecific antibody to TNBC and PDAC’.

Antibody 62

Antibody Engineer Protein Scientist 62